Neogenomics (NEO) Short-term Investments (2020 - 2025)

Neogenomics (NEO) has reported Short-term Investments for 6 consecutive years, with $9.0 million the latest figure, recorded in Q2 2025.

• Short-term Investments for Q2 2025 came in at $9.0 million, down 72.65% year-over-year; the trailing twelve-month figure through Jun 2025 was $9.0 million (down 72.65% YoY), and the FY2024 annual result was $19.8 million, down 72.73% from the prior year.
• Short-term Investments was $9.0 million for Q2 2025 at Neogenomics, down from $11.9 million in the prior quarter.
• Over five years, Short-term Investments peaked at $203.0 million in Q2 2021 and troughed at $9.0 million in Q2 2025.
• Average Short-term Investments over 5 years is $116.0 million, with a median of $131.3 million recorded in 2023.
• Year-over-year, Short-term Investments surged 301.28% in 2021 and plunged 77.54% in 2025.
• Over 5 years, Short-term Investments stood at $198.6 million in 2021, then decreased by 11.96% to $174.8 million in 2022, then tumbled by 58.4% to $72.7 million in 2023, then sank by 72.73% to $19.8 million in 2024, then slumped by 54.81% to $9.0 million in 2025.
• Per Business Quant data, the three most recent Short-term Investments figures were $9.0 million in Q2 2025, $11.9 million in Q1 2025, and $19.8 million in Q4 2024.